Maxcyte, Inc. · NASDAQ:MXCT
BlackRock, Inc.'s stake in Maxcyte, Inc. fell to 1.30% (Schedule 13G/A)
Event Jun 30, 2026 · Filed Jul 29, 2026
BlackRock, Inc.'s stake in Maxcyte, Inc. fell to 1.30%, 1,402,591 shares, as a passive investor on Jun 30, 2026. Filed Jul 29, 2026 (Schedule 13G/A).
- Stake
- 1.30%
- Shares
- 1,402,591
- Intent
- Passive
- What changed
- Fell below 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 1.30% | 1,402,591 |
Source
Related
- Maxcyte, Inc.
- BlackRock, Inc.
- Maxcyte, Inc. shareholders
- Schedule 13G/A · BlackRock, Inc. · Jan 21, 2026
- Schedule 13G/A · BlackRock, Inc. · Feb 5, 2025
- Schedule 13D · Liontrust Investment Partners LLP · Oct 15, 2026
- Schedule 13D · River Global Investors LLP · Aug 4, 2026
- Form 4 · Johnston John Joseph · Jun 22, 2026
- Form 4 · Hemrajani Rekha · Jun 22, 2026
- Form 4 · Erck Stanley C · Jun 22, 2026